Radioimmunoassay for hepatitis B core antigen

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Serum hepatitis B core antigen (HBcAg) is a key indicator of hepatitis B virus (HBV) replication.
• Accurate detection of HBcAg is crucial for diagnosing and managing chronic hepatitis B infections.

Purpose of the Study:

• To develop and validate an easy and sensitive radioimmunoassay (RIA) for quantifying serum HBcAg.
• To evaluate the presence of HBcAg in patients with different forms of chronic hepatitis and healthy volunteers.

Main Methods:

• A competitive inhibition radioimmunoassay was developed using components from commercial anti-core kits.
• The assay measures HBcAg by inhibiting the binding of radiolabeled antibodies to HBcAg-coated beads.
• Serum samples from 49 HBsAg-positive chronic hepatitis patients, 50 HBsAg-negative chronic hepatitis patients, and 30 healthy volunteers were analyzed.

Main Results:

• HBcAg was detected in 41% of patients with HBsAg-positive chronic hepatitis.
• No HBcAg was detected in patients with HBsAg-negative chronic hepatitis or healthy volunteers.
• Hepatitis Be antigen (HBeAg) was not detected in 50% of HBcAg-positive sera, suggesting a potential dissociation between HBcAg and HBeAg presence.

Conclusions:

• The developed radioimmunoassay provides a sensitive and straightforward method for detecting serum HBcAg.
• The presence of HBcAg correlates with HBsAg positivity in chronic hepatitis B patients.
• The assay's findings contribute to a better understanding of hepatitis B virus replication markers.